Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): Evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users

Substance Abuse: Treatment, Prevention, and Policy

Volumn 10, Issue 1, 2015, Pages

  Petróczi, Andrea ^a   Ocampo, Jorge A Vela ^a   Shah, Iltaf ^a   Jenkinson, Carl ^b   New, Rachael ^c   James, Ricky A ^a   Taylor, Glenn ^c   Naughton, Declan P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c HAMPSHIRE COUNTY COUNCIL   (United Kingdom)

Author keywords

Body fat; Bodybuilding; DNP; Exercise; Health risk; Illicit drug; LC MS MS; Sport; Supplement; Weight loss

Indexed keywords

2,4 DINITROPHENOL; ANTIOBESITY AGENT;

ADULT; ANALYSIS; ATHLETE; ATTITUDE TO HEALTH; COMMERCIAL PHENOMENA; DIETARY SUPPLEMENT; DRUG CONTAMINATION; ECONOMICS; FEMALE; HEALTH SURVEY; HUMAN; INTERNET; MALE; MOTIVATION; PSYCHOLOGY; YOUNG ADULT;

2,4-DINITROPHENOL; ADULT; ANTI-OBESITY AGENTS; ATHLETES; COMMERCE; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INTERNET; MALE; MOTIVATION; YOUNG ADULT;

EID: 84944408821     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/s13011-015-0034-1     Document Type: Article

References (91)

1. James WPT. The epidemiology of obesity: the size of the problem. J Internal Med. 2008;263(4):336-52.
2. Müller-Riemenschneider F, Reinhold T, Berghöfer A, Willich SN. Health-economic burden of obesity in Europe. Eur J Epidemiol. 2008;23(8):499-509.
3. Ford ES, Mokdad AH. Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metabol. 2008;93:s1-8.
4. Yuliana ND, Jahangir M, Korthout H, Choi YH, Kim HK, Verpoorte R. Comprehensive review on herbal medicine for energy intake suppression. Obes Rev. 2011;12:499-514.
5. Kim HJ, Lee JH, Park HJ, Cho SH, Cho S, Kim WS. Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31:777-83.
6. Monakhova YB, Kuballa T, Löbell-Behrends S, Hengen J, Maixner S, Kohl-Himmelseher M, et al. 1H NMR screening of pharmacologically active substances in weight-loss supplements being sold online. Lebensmittelchemie. 2012;66(6):147-50.
7. Rebiere H, Guinot P, Civade C, Bonnet PA, Nicolas A. Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29:161-71.
8. Lachenmeier DW, Löbell-Behrends S, Böse W, Marx G. Does European Union food policy privilege the internet market? Suggestions for a specialized regulatory framework. Food Control. 2013;30:705-13.
9. Cohen PA, Goday A, Swann JP. The return of rainbow diet pills. Am J Public Health. 2012;102:1676-86.
10. Yen M, Ewald MB. Toxicity of weight loss agents. J Med Toxicol. 2012;8:145-52.
11. Miranda EJ, McIntyre IM, Parker DR, Gary RD, Logan BK. Two deaths attributed to the use of 2,4 dinitrophenol. J Anal Toxicol. 2006;30:219-22.
12. Grundlingh J, Dargan PI, El-Zanfaly M, Wood DM. 2,4-Dinitrophenol (DNP): A weight loss agent with significant acute toxicity and risk of death. J Med Toxicol. 2011;7:205-12.
13. Kamour A, George N, Gwynnette D, Cooper G, Lupton D, Eddleston M, et al. Increasing frequency of severe clinical toxicity after use of 2, 4-dinitrophenol in the UK: a report from the National Poisons Information Service. Emerg Med J. 2014;doi: 10.1136/emermed-2013-203335.
14. Lee HCH, Law CY, Chen ML, Lam YH, Chan AYW, Mak TWL. 2, 4-Dinitrophenol: A threat to Chinese body-conscious groups. J Chin Med Assoc. 2014;77:443-6.
15. Food Standards Agency. Warning about 'fat-burner' substances containing DNP. http://www.food.gov.uk/news-updates/news/2012/5371/dnp-warning. Accessed on 06 April 2015.
16. Food Standards Agency. Help prevent another DNP death. http://www.food.gov.uk/news-updates/news/2013/5833/dnp. Accessed on 06 April 2015.
17. Wise J. Increase in reports of toxicity from fat burning supplement seen in UK. BMJ. 2014;348:g4188.
18. Lemon TI. 2, 4 Dinitrophenol - a danger for patients with drug use issues and eating disorders alike. J Sports Med Doping Stud. 2013;3:121.
19. Petróczi A, Naughton DP. Potentially fatal new trend in performance enhancement: a cautionary note on nitrite. J Int Soc Sports Nutr. 2010;7:25.
20. Pomeranz JL, Barbosa G, Killian C, Austin SB. The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. J Public Health Manag Pract. 2014; doi: 10.1097/PHH.0000000000000142.
21. Harper JA, Dickinson K, Brand MD. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes Rev. 2001;2:255-65.
22. Le P, Wood B, Kumarasinghe SP. Cutaneous drug toxicity from 2, 4-dinitrophenol (DNP): Case report and histological description. Australas J Dermatol. 2014; doi: 10.1111/ajd.12237.
23. Reid SL, Salmond J, Datta S, Underwood MA, Akhtar MN. Dietary supplement 2, 4-dinitrophenol resulting in Fournier's gangrene. JCU. 2014; doi: 10.1177/2051415814551379.
24. TO2). Can J Physiol Pharm. 2000;78:766-73.
25. Wu SN, Li HF, Chiang HT. Characterization of ATP-sensitive potassium channels functionally expressed pituitary cells. J Membr Biol. 2000;178:205-14.
26. Agency for Toxic Substances & Disease Registry. Public health statement. dinitrophenols. CAS ID: 51-28-5 (2,4-DNP). 1995. http://www.atsdr.cdc.gov/ToxProfiles/tp64-c1-b.pdf. Accessed on 06 April 2015.
27. National Health Service. New warnings issued over deadly DNP 'diet drug'. http://www.nhs.uk/news/2014/01January/Pages/New-warnings-issued-over-deadly-DNP-diet-drug.aspx. Issued on 15/01/2014. Accessed on 06 April 2015.
28. National Health Service. Warnings issued over deadly DNP diet drug. http://www.nhs.uk/news/2013/09September/Pages/Warnings-issued-over-deadly-DNP-diet-drug.aspx Accessed on 06 April 2015.
29. FSA action over DNP 'fat burner substances'. http://www.food.gov.uk/news-updates/news/2013/5772/dnp. Accessed on 06 April 2015.
30. Risks of buying medicines over the Internet. http://www.nidirect.gov.uk/risks-of-buying-medicines-over-the-internet. Accessed on 11 October 2015.
31. Montoya ID, Jano E. Online pharmacies: safety and regulatory considerations. Int J Health Serv. 2007;37:279-89.
32. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow. and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012;8:15-32.
33. Schmidt MM, Sharma A, Schifano F, Feinmann C. "Legal highs" on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int. 2011;206:92-7.
34. Hoxha B, Petróczi A. Playing with fire? Factors influencing risk willingness with unlicensed fat burner drug 2,4-Dinitrophenol (DNP) in young adults. Publ Health. 2015. doi: 10.1016/j.puhe.2015.03.013.
35. Redlich-Amirav D, Higginbottom G. New emerging technologies in qualitative research. Qual Report. 2014;19(26):1-14.
36. Holtz P, Kronberger N, Wagner W. Analyzing internet forums. A practical guide. J Media Psychol - GER. 2012;24:55-66.
37. Im EO, Chee W. Practical guidelines for qualitative research using online forums. Comput Inform Nurs. 2012;30:604-11.
38. Number 19 of the Food Labelling Regulations 1996, as amended by the Food Labelling (Amendment) Regulations 1998 and the Food Labelling (Amendment) (No. 2) Regulations 1999. The National Archives [ http://www.legislation.gov.uk/uksi/1996/1499/contents/made ]
39. Westaby JD. Behavioural reasoning theory: identifying new linkages underlying intentions and behaviour. Organ Behav Hum. 2005;98:97-120.
40. Müller CP, Schumann G. Drugs as instruments: A new framework for non-addictive psychoactive drug use. Behav Brain Sci. 2011;34:293-310.
41. Marteau TM, Dormandy E, Mitchie S. A measure of informed choice. Health Expect. 2001;4:99-108.
42. Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Experiment Psychol Gen. 2012;141(1):2-18.
43. Richardson JTE. Eta squared and partial eta squared as measures of effect size in educational research. Educational Res Rev. 2011;6:135-47.
44. nd Ed.). New York: Academy Press; 1988. p. 280-7.
45. Johnson VE. Revised standards for statistical evidence. Proc Natl Acad Sci U S A. 2013;110(48):19313-7.
46. st Ed.). Thousand Oaks:Sage 2001. http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-R5.php.
47. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks:Sage
48. Braun V, Clarke V, Terry G. Thematic analysis. In P Rohleder, EC Lyons Editors. Qualitative Research in Clinical and Health Psychology, 2015; 95-113. New York: Palgrave Macmillan.
49. King RA, Racherla P, Bush VD. What we know and don't know about online word-of-mouth: A review and synthesis of the literature. J Interact Marketing. 2014;28:167-83.
50. Utz S, Kerkhof P, van den Bos J. Consumers rule: How consumer reviews influence trustworthiness of online stores. Electronic Commerce Res Appl. 2012;11:49-58.
51. Eastlick MA, Lotz S. Cognitive and institutional predictors of initial trust toward an online retailer. Int J Retail Distrib Management. 2011;39:234-55.
52. Beldad A, de Jong M, Steehouder M. How shall I trust the faceless and the intangible? A literature review on the antecedents of online trust. Comp Human Behav. 2010;26:857-69.
53. Davey Z, Schifano F, Corazza O, Deluca P. e-Psychonauts: conducting research in online drug forum communities. J Mental Health. 2012;21(4):386-94.
54. Orsolini L, Duccio Papanti G, Francesconi G, Schifano F. Mind navigators of chemicals' experimenters? A web-based description of E-psychonauts. Cyberpsychol, Behav Social Networking. 2015;18(5):296-300.
55. Miller S-J. Healthy weight & height for bodybuilding. 2014. http://www.livestrong.com/article/372555-healthy-weight-height-for-bodybuilding/. Accessed on 06 April 2015.
56. Moody A. Adult anthropometric measures, overweight and obesity. In Craig R, Mindell J, editors. Health Survey for England - 2012 (Report). Volume 1: Health, social care and lifestyles. Health and Social Care Information Centre. 2013. http://www.hscic.gov.uk/catalogue/PUB13218/HSE2012-Ch10-Adult-BMI.pdf
57. Jansen KL, Prast CJ. Psychoactive properties of mitragynine (kratom). J Psychoactive Drug. 1988;20(4):455-7.
58. st, 2015. http://www.telegraph.co.uk/women/womens-health/11552359/Diet-pills-I-know-the-danger-but-I-want-them-anyway.html
59. rd. 2015. http://www.itv.com/news/2015-07-23/heart-problems-and-heroin-welcome-to-the-world-of-slimming-pills/
60. Neumark-Sztainer D, Wall M, Larson NI, Eisenberg ME, Loth K. Dieting and disordered eating behaviors from adolescence to young adulthood: findings from a 10-year longitudinal study. J Am Dietetic Assoc. 2011;111(7):1004-11.
61. Haedt AA, Keel PK. Comparing definitions of purging disorder on point prevalence and associations with external validators. Int J Eating Disorder. 2010;43(5):433-9.
62. Reba-Harrelson L, Von Holle A, Thornton LM, Klump KL, Berrettini WH, Brandt H, et al. Features associated with diet pill use in individuals with eating disorders. Eating Behav. 2008;9(1):73-81.
63. th 2015. http://www.theguardian.com/uk-news/2015/jul/25/diet-pills-website-parry-student-death
64. Rawstorne T. Killed by the tablets they took to lose weight: This beautiful student doctor was killed by internet slimming pills that make users fatally overheat. And she is far from the only victim. The Mail on Sunday; 26 April 2013. http://www.dailymail.co.uk/femail/article-2315433/Sarah-Houston-cause-death-Boiled-alive-internet-slimming-pills-DNP.html
65. th, 2014. http://www.theguardian.com/uk-news/2014/jul/08/man-killed-herbicide-weight-loss-aid-court-hears
66. th June, 2015. http://www.independent.ie/breaking-news/irish-news/man-dies-after-taking-diet-pills-31330421.html
67. Petróczi A, Mazanov J, Naughton DP. Inside athletes' minds: Preliminary results from a pilot study on mental representation of doping and implications for anti-doping. Subst Abuse Treat Prev Policy. 2011;6:10.
68. Uvacsek M, Ránky M, Nepusz T, Naughton DP, Mazanov J, Petroczi A. Self-admitted behaviour and perceived use of performance enhancing versus psychoactive drugs among competitive athletes. Scand J Med Sci Sports. 2011;21(2):224-34.
69. Petroczi A. The doping mindset - Part I: Implications of the functional use theory on mental representations of doping. PEH. 2013;2:153-63.
70. Petróczi A, Mazanov J, Naughton DP. Inside athletes' minds: Preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping. Subst Abuse Treatment Prev Policy. 2011;6:10.
71. Fincoeur B, Frenger M, Pitsch W. Does one play with the athletes' health in the name of ethics? PEH. 2013;2:182-93.
72. Fincoeur B, Van de Ven K, Mulrooney KJ. The symbiotic evolution of anti-doping and supply chains of doping substances: how criminal networks may benefit from anti-doping policy. Trends Organ Crime. 2014; doi: 10.1007/s12117-014-9235-7.
73. Becker GS. Crime and punishment: An economic approach. In: Becker GS, Landes WM, editors. Essays in the economics of crime and punishment. Research.: National Bureau of Economic; 1974. p. 1-54.
74. Hoehn KL, Turner N, Swarbrick MM, Wilks D, Preston E, Phua Y, et al. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab. 2010;11:70-6.
75. Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demographics, motivations and patterns of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007;4:12.
76. Monaghan LF. Vocabularies of motive for illicit steroid use among bodybuilders. Social Sci Med. 2002;55(5):695-708.
77. Christiansen AV, Bojsen-Møller J. "Will steroids kill me if I use them once?" A qualitative analysis of inquiries submitted to the Danish anti-doping authorities. PEH. 2012;1(1):39-47.
78. Boardley ID, Grix J. Doping in bodybuilders: A qualitative investigation of facilitative psychosocial processes. Qual Res Sport Exerc Health. 2014;6(3):422-39.
79. Boardley ID, Grix J, Dewar AJ. Moral disengagement and associated processes in performance-enhancing drug use: a national qualitative investigation. J Sport Sci. 2014;32(9):836-44.
80. Boardley ID, Grix J, Harkin J. Doping in team and individual sports: a qualitative investigation of moral disengagement and associated processes. Qual Res Sport Exerc Health. 2015;7(5):698-717.
81. Todd T. Anabolic steroids: the gremlins of sport. J Sport Hist. 1987;14:87-107.
82. Bandura A. Moral disengagement in the perpetration of inhumanities. Pers Soc Psychol Rev. 1999;3(3):193-209.
83. Pappa E, Kennedy E. 'It was my thought. he made it a reality': Normalization and responsibility in athletes' accounts of performance-enhancing drug use. Int Rev Sociol Sport. 2013;48(3):277-94.
84. Bilard J, Ninot G, Hauw D. Motives for illicit use of doping substances among athletes calling a national antidoping phone-help service: an exploratory study. Subst Use Misuse. 2011;46(4):359-67.
85. Ohl F, Fincoeur B, Lentillon-Kaestner V, Defrance J, Brissonneau C. The socialization of young cyclists and the culture of doping. Int Rev Sociol Sport. 2013; doi: 1012690213495534.
86. Overbye M, Knudsen ML, Pfister G. To dope or not to dope: Elite athletes' perceptions of doping deterrents and incentives. PEH. 2013;2(3):119-34.
87. Walsh C. Drugs, the Internet and change. J Psychoactive Drugs. 2011;43:55-63.
88. Soussan C, Kjellgreen A. Harm reduction and knowledge exchange - a qualitative analysis of drug-related Internet discussion forums. Harm Reduct J. 2014;11:25.
89. Brennan R, Van Hout MC, Wells J. Heuristics of human enhancement risk: a little chemical help? Int J Health Promot Educ. 2013;51(4):212-27.
90. Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI. Controlled-release mitochondrial protonophore reverses diabetes and protonophore reverses diabetes and steatohepatitis in rats. Science. 2015;347(6227):1253-6.
91. Advisory Council on the Misuse of Drugs. Prevention of drug and alcohol dependence. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/406926/ACMD_RC_Prevention_briefing_250215.pdf.